Crossmark

Reasons for Delayed Anti-VEGF Treatment During COVID-19 Lockdown and Clinical Impact in Neovascular Age-Related Macular Degeneration

Published Online: 2023-07-04

Published Print: 2023-10

Authors

Zarranz-Ventura, Javier

Escobar-Barranco, José J.

Gómez-Baldó, Laia

Gallego-Pinazo, Roberto

,
Funding

Funding for this research was provided by:

Novartis Farmacéutica
License Information

Text and Data Mining valid from 2023-07-04

Version of Record valid from 2023-07-04
More Information

Article History

Received: 9 May 2023

Accepted: 8 June 2023

First Online: 4 July 2023

Document is current